Daniel Terheyden-Keighley

Company: Catalent Pharma Solutions

Job title: Research & Development Scientist

Seminars:

From Bench to Patient Cure: Unlocking iPSC Potential through Innovative Science & Strategic Partnerships 10:00 am

iPSCs: the promise of a new wave of advanced cell therapies Speed to clinic with GMP iPSC cell lines GMP-compatible gene editing and differentiation methodologies Novel differentiation platform for immune cells, iNK, iRPE, iMSCs and cardiac cells Partnerships that can accelerate the journey from bench to clinic and commercial by accessing platforms, IP and ‘Know-How’.Read more

day: Conference Day One